(R)-Hexahydropyrrolo[1,2-a]pyrazin-6(2H)-one is a chiral bicyclic lactam compound featuring a fused pyrrolidine and piperazinone ring system. Its (R)-enantiomer is a key structural motif and a crucial synthetic intermediate in medicinal chemistry. This compound is primarily recognized as a critical chiral building block for the synthesis of pharmaceutical agents targeting the central nervous system. It serves as a core scaffold in the development of orexin receptor antagonists, a class of drugs investigated for the treatment of insomnia. The specific stereochemistry of the (R)-enantiomer is essential for achieving the desired biological activity and binding affinity in these drug candidates. As a high-value pharmaceutical intermediate, its synthesis and supply are of significant importance in the research and development pipelines of several neuroactive drugs. Its application underscores the role of complex, enantiopure heterocycles in modern drug discovery.